Less Small-Bowel Injury With Lumiracoxib Compared With Naproxen Plus Omeprazole-Reference-Cited by-同舟云学术

Less Small-Bowel Injury With Lumiracoxib Compared With Naproxen Plus Omeprazole

Published:2008-05 Issue:5 Volume:6 Page:536-544
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Hawkey Christopher J.,Ell Christian,Simon Bernd,Albert Jörg,Keuchel Martin,McAlindon Mark,Fortun Paul,Schumann Stefan,Bolten Wolfgang,Shonde Anthony,Hugot Jean–Louis,Yu Vincent,Arulmani Udayasankar,Krammer Gerhard,Rebuli Rosemary,Toth Ervin

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference51 articles.

1. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs;Bjarnason;Lancet,1984

2. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man;Bjarnason;Gut,1991

3. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin;Sigthorsson;Gut,2000

4. Intestinal permeability and inflammation in patients on NSAIDs;Sigthorsson;Gut,1998

5. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs;Allison;N Engl J Med,1992

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differenzialdiagnosen von Kolitiden;Gastroenterologie up2date;2023-06

2. Proton Pump Inhibitors Increase the Risk of Nonsteroidal Anti-inflammatory Drug-Related Small-Bowel Injury: A Systematic Review With Meta-analysis;Clinical and Translational Gastroenterology;2023-04-05

3. Small bowel obstruction: what a gastroenterologist needs to know;Current Opinion in Gastroenterology;2023-03-02

4. Effect of the combination of mexidol and diclofenac sodium on exudative inflammation in rats after ten-day preventive oral administration;Pharmacokinetics and Pharmacodynamics;2022-05-01

5. Gastrointestinal and cardiovascular adverse events associated with NSAIDs;Expert Opinion on Drug Safety;2021-08-18